embedded image ;and salts, solvates, pharmaceutical compositions, and dosage forms thereof, for use in methods of treating negative symptoms and disorders (e.g., autism disorders, amblyopia, personality disorders, traumatic brain injury), as well as increasing neuroplasticity and promoting neuroprotection in subjects in need thereof."/> USE OF ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISORDERS, INCREASE NEUROPLASTICITY, AND PROMOTE NEUROPROTECTION
首页> 外国专利> USE OF ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISORDERS, INCREASE NEUROPLASTICITY, AND PROMOTE NEUROPROTECTION

USE OF ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISORDERS, INCREASE NEUROPLASTICITY, AND PROMOTE NEUROPROTECTION

机译:使用鲁哌啶酮治疗阴性症状和疾病,增加神经可塑性和促进神经保护

摘要

The present application relates to the use of roluperidone, i.e., Compound (I):; embedded image ;and salts, solvates, pharmaceutical compositions, and dosage forms thereof, for use in methods of treating negative symptoms and disorders (e.g., autism disorders, amblyopia, personality disorders, traumatic brain injury), as well as increasing neuroplasticity and promoting neuroprotection in subjects in need thereof.
机译:本申请涉及罗哌啶酮,即化合物(I)的用途: “嵌入式图像” ;及其盐,溶剂化物,药物组合物及其剂型,用于治疗阴性症状和病症(例如自闭症,弱视,人格障碍,脑外伤),以及增加受试者的神经可塑性和促进神经保护作用的方法需要它。

著录项

  • 公开/公告号US2020061046A1

    专利类型

  • 公开/公告日2020-02-27

    原文格式PDF

  • 申请/专利权人 MINERVA NEUROSCIENCES INC.;

    申请/专利号US201916547164

  • 发明设计人 REMY HENRI LUTHRINGER;

    申请日2019-08-21

  • 分类号A61K31/454;A61P25/28;

  • 国家 US

  • 入库时间 2022-08-21 11:21:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号